Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 4, 2005Journal of Leukocyte Biology

Interleukin-10 and the immune response against cancer: a counterpoint

View Full Paper
Ask AI
Bookmark
Share

Authors

SMSimone MocellinUniversity of PaduaFMFrancesco M. MarincolaFleet Science CenterHoward A. YoungHoward A. YoungThe Wistar Institute

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mocellin et al. (2005) studied this question.

synapsesocial.com/papers/6a1bd65d0a1f7575939d0786https://doi.org/10.1189/jlb.0705358
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Results From a Randomized Phase III Study Comparing Combined Treatment With Histamine Dihydrochloride Plus Interleukin-2 Versus Interleukin-2 Alone in Patients With Metastatic Melanoma2002 · 164 citations
  2. 2Split activity of interleukin‐10 on antigen capture and antigen presentation by human dendritic cells: Definition of a maturative step1997 · 122 citations
  3. 3In VivoEffects of IL-4, IL-10, and Amifostine on Cytokine Production in Patients with Acute Myelogenous Leukemia2001 · 18 citations
  4. 4Human IL-10 is a chemoattractant for CD8+ T lymphocytes and an inhibitor of IL-8-induced CD4+ T lymphocyte migration.1993 · 183 citations
  5. 5Differential expression of Toll-like receptor 2 in human cells2001 · 255 citations